Treatment of Mycobacterium Avium Complex

Introduction to Treatment Regimens

The American College of Cardiology is not relevant here, however, treatment should be initiated with a macrolide-based three-drug regimen consisting of azithromycin (or clarithromycin) plus ethambutol, with or without rifampin, continued for 12 months after sputum culture conversion, as recommended by other guideline societies 1

If a patient has disseminated MAC (positive blood cultures), treatment differs dramatically and requires immediate multi-drug therapy, according to the Centers for Disease Control and Prevention (CDC) 2, 3
For pulmonary MAC (sputum/respiratory specimens), treatment decisions depend on meeting full diagnostic criteria, not just culture positivity, as stated by the Infectious Diseases Society of America (IDSA) 1

For disseminated disease, initiate at least two-drug therapy immediately, with every regimen containing either azithromycin or clarithromycin plus ethambutol as the preferred second agent, as recommended by the CDC 4, 5
The standard disseminated MAC regimen includes clarithromycin 500 mg orally twice daily or azithromycin 500 mg orally daily, and ethambutol 15 mg/kg orally once daily, according to the National Institutes of Health (NIH) 6, 2, 7
Consider adding rifabutin 300 mg daily, rifampin 600 mg daily, ciprofloxacin 750 mg twice daily, clofazimine 100-200 mg daily, or amikacin 7.5-15 mg/kg daily, as suggested by the IDSA 2, 3

For pulmonary disease, the preferred regimen is azithromycin 500 mg daily plus ethambutol 15 mg/kg daily, with or without rifampin 450-600 mg daily (or rifabutin 300 mg daily), continued for 12 months after sputum culture conversion, as recommended by the American Thoracic Society (ATS) 1

For disseminated MAC in HIV patients, lifelong suppressive therapy is mandatory after initial treatment, according to the CDC 1
Do not discontinue maintenance therapy even if CD4+ counts improve to >100 cells/mm³ with antiretroviral therapy, as stated by the NIH 1
Rifabutin 300 mg daily is recommended for prophylaxis in HIV patients with CD4+ counts <100 cells/μL, according to the IDSA 4, 5

Monitor fever, weight loss, and night sweats several times during initial weeks, as recommended by the CDC 4
Obtain monthly sputum cultures until conversion, then every 3 months, according to the ATS 1
Chest CT at 6-12 month intervals to assess radiographic response, as suggested by the IDSA 1

Define treatment failure as no clinical improvement after 3-6 months or persistent positive cultures after 6 months, according to the IDSA 1
Alternative agents for refractory disease are not well established, but may include clofazimine, amikacin liposomal inhalation, linezolid, bedaquiline, or fluoroquinolones, although evidence is limited 1

Do NOT treat colonization: Ensure full diagnostic criteria are met before initiating therapy, as MAC isolation alone does not mandate treatment, according to the IDSA 1
Do NOT use monotherapy: Always use combination therapy to prevent resistance development, as recommended by the CDC and IDSA 2, 3, 4
Do NOT stop therapy prematurely: Treatment must continue for 12 months after culture conversion, not just symptom resolution, according to the ATS and IDSA 1